Background/Aim: Colorectal cancer is a common type of cancer with reported resistance to treatment, in most cases due to loss of function of apoptotic and cell-cycle proteins. Piperlongumine (PPLGM) is a natural alkaloid isolated from Piper species, with promising anti-cancer properties. This study investigated whether PPLGM is able to induce cell death in colorectal carcinoma HCT 116 cells expressing wild-type or deficient in Bax, p21 or p53. Materials and Methods: PPLGM was extracted from roots of Piper tuberculatum. Cell viability was determined by reduction of 3-(4,5-dimethilthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and clonogenic assay. Cell death was evaluated by acridine orange/ethidium bromide staining and flow cytometry. Plasmid cleavage activity and circular dichroism DNA interaction were also analyzed. Results: PPLGM induced selective cell death in all cell lines (IC 50 range from 10.7 to 13.9 μM) with an increase in the number of late apoptotic cells and different profiles in cell-cycle distribution. Plasmid DNA analysis showed that PPLGM does not interact directly with DNA. Conclusion: This paper suggests that PPLGM may be a promising candidate in colorectal cancer therapy. According to the last GLOBOCAN publication (2012), colorectal cancer is the third most common malignancy in men and the second in women worldwide. Chemotherapeutic resistance and toxicity found in this type of cancer reinforce the need for alternative therapies. Extracts from Piper plants have been used in the treatment of different pathologies for centuries (1). Piperlongumine (PPLGM) is an alkaloid obtained from Piper species with promising anticancer activity. Raj et al. in 2011 (2), reported that PPLGM induces cancer-selective cell death by elevating reactive oxygen species (ROS) levels, through inhibition of the antioxidant enzyme glutathione S-transferase. As cancer cells have increased ROS levels compared to normal cells, they were more susceptible to cell death induced by oxidative stress (3, 4). This therapeutic strategy has been extensively studied to selectively kill cancer cells (5, 6). Cell death induced by PPLGM has been related to apoptotic signals such as increased p53 and PUMA expression, cleaved caspase-3, decreased bcl-2 expression and DNA fragmentation (1, 7). However, some studies show that PPLGM activates autophagy in the presence of apoptotic inhibitors (8, 9). In colon cancer cell lines, PPLGM seems to work, at least in part, through the JNK and MEK/ERK pathways, by activating JNK and ERK, which can induce apoptotic enzymes or phosphorylate transcription factors that regulate the expression of pro-apoptotic genes (10, 11). Apoptosis is a programmed cell death mechanism that occurs through two major pathways: the extrinsic pathway induced by extracellular stress signals and propagated by specific transmembrane receptors, and the intrinsic pathway, mediated by mitochondrial outer membrane permeabilization (12). p53 is a tumor-suppressor protein that induces cellcycle arrest, apoptosis or senescence ...